Greg Madison

Greg Madison serves as CEO at Keryx Biopharmaceuticals. Keryx Biopharmaceuticals operates in the research sector with approximately 270.0 employees. The company is headquartered in Boston, Massachusetts. Keryx Biopharmaceuticals generates annual revenue of 160200000.0.

Industry & Role Insights

• • MessageCEO tracks 2,961 executives in the research sector.
• • 3,781 executive contacts are available in Massachusetts.
• • Our database includes 201,469 c suite-level executives.

Salesforce Mimecast Outlook Microsoft Office 365 ZoneEdit Google Cloud Hosting Drupal WP Engine OneTrust Google Tag Manager Google Font API SilkRoad New Relic WordPress.org Mobile Friendly YouTube Google Analytics Remote AI

healthcare biotechnology life sciences biotechnology: pharmaceutical preparations health care biotechnology research kidney disease renal care biopharmaceutical chronic kidney disease (ckd) fda-approved anemia epo (erythropoietin) hif-phi (hypoxia-inducible factor prolyl hydroxylase inhibitors) clinical trials commercialization patient resources auryxia vafseo collaboration partnership renal community therapeutics innovation outcomes research & development chronic kidney disease treatment nephrology patient advocacy iron deficiency anemia hyperphosphatemia dialysis renal function nephrology-focused clinical development transforming kidney care medical professionals access to medications long-term outcomes patient services disease management healthcare partnerships related therapies health outcomes drug development biological drugs acquisitions licensing agreements global health pharmaceutical partnerships clinical data healthcare innovation patient-centric care scientific research biopharmaceuticals chronic kidney disease ckd hypoxia-inducible factor hif-phi vadadustat ferric citrate renal therapeutics metabolic disorders innovative therapies patient-centered care healthcare professionals ischemia vascular diseases fda-approved products commercial launch market expansion precision medicine unmet medical needs patient impact healthcare providers biopharmaceutical innovation commercial supply contracts patient demographics quality of life therapeutic focus bold innovation partnerships financial performance customer segments health wellness & fitness hospital & health care

SN

Srikanth Nandiraju Chief Technology Officer at 1Cell.Ai Inc.

SD

Surinnder Dang Chief Business Officer at 1Cell.Ai Inc.

M

Mark Chief Executive Officer at 23Strands

IT

Ilia Tikhomirov Chief Executive Officer at 35Pharma

AD

Alistair Draffan Chief Executive Officer at 360biolabs Pty Ltd

Outreach Guidance — research Sector

Executives like Greg Madison in the research sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at Keryx Biopharmaceuticals.

Greg Madison's Position in the MessageCEO Database

• •2,871 verified executive contacts in research are in the MessageCEO database.
• •3,577 verified executive contacts in Massachusetts are in the database.
• •18 verified contacts work at research companies in the 270.0 employee range (same size as Keryx Biopharmaceuticals).

Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated July 2026.

How do I reach Greg Madison directly?

Greg Madison's verified email address is available to MessageCEO Pro subscribers. They currently serve as CEO at Keryx Biopharmaceuticals. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Greg Madison work for?

Greg Madison is CEO at Keryx Biopharmaceuticals, a company in the research sector with 270.0 employees. The company is based in Boston, Massachusetts.

Can I pitch or sell to Greg Madison?

As CEO at Keryx Biopharmaceuticals, Greg Madison is a key decision-maker in the research sector. MessageCEO Pro gives you verified email to reach Greg Madison directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Greg Madison in?

Greg Madison works in the research industry as CEO at Keryx Biopharmaceuticals. MessageCEO provides verified contact information for executives across all major industries.

Is Greg Madison's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Greg Madison's profile is kept up-to-date with the latest available information.

Last updated: July 22, 2026